Medicofarma Biotech SA (WSE:MDB)
Poland
· Delayed Price · Currency is PLN 0.474
+0.005 (1.07%)
At close: Mar 6, 2026
Medicofarma Biotech Revenue
Medicofarma Biotech had revenue of 7.90K PLN in the quarter ending September 30, 2025, with 37.15% growth. This brings the company's revenue in the last twelve months to 281.45K, down -73.64% year-over-year. In the year 2024, Medicofarma Biotech had annual revenue of 1.22M with 63.14% growth.
Revenue (ttm)
281.45K
Revenue Growth
-73.64%
P/S Ratio
114.49
Revenue / Employee
46.91K
Employees
6
Market Cap
32.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22M | 474.05K | 63.14% |
| Dec 31, 2023 | 750.81K | -3.50M | -82.34% |
| Dec 31, 2022 | 4.25M | 915.81K | 27.45% |
| Dec 31, 2021 | 3.34M | -313.69K | -8.59% |
| Dec 31, 2020 | 3.65M | 465.77K | 14.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 706.45M |
| Voxel | 568.83M |
| Sygnis | 11.34M |
| Pharmena | 1.58M |
| Pure Biologics | -10.52M |
| Airway Medix | -5.00K |